Point of care testing for human chorionic gonadotropin, creatinine, and blood urea nitrogen: cost-effectiveness
CADTH
Record ID 32014000136
English
Authors' recommendations:
One economic evaluation was identified regarding the cost-effectiveness of point of care testing for creatinine; no literature was identified regarding the cost-effectiveness of point of care testing for human chorionic gonadotropin or blood urea nitrogen.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jul-2013/RA0626%20POC%20Economics%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Chorionic Gonadotropin
- Creatinine
- Blood Urea Nitrogen
- Point-of-Care Systems
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.